Comparative effects of propofol and remimazolam on US-guided radiofrequency ablation of hepatic neoplasm under monitored anesthesia care
Not Applicable
- Conditions
- Neoplasms
- Registration Number
- KCT0007246
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
1) Patients planning to undergo ultrasound-guided liver radiofrequency ablation under supervised anesthesia
2) Adult male and female patients between the ages of 20 and 80
3) Patients who voluntarily consented in writing to participate in this clinical trial
4) Patients falling under ASA classification 1-2
Exclusion Criteria
1) If the patient does not consent to participate in the study
2) If you have previously been allergic to propofol or remimazolam
3) If the modified Allen's test is negative
4) In case of serious cardiovascular or cerebrovascular disease
5) If you have serious lung disease
6) In case of severe liver cirrhosis
7) Other patients determined by the researcher to be inappropriate
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ABGA
- Secondary Outcome Measures
Name Time Method Vital signs;Iowa satisfaction with anesthesia scale